FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research
now for free  

Experts in Selegiline

A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

Flash Player Required

Copyright © 2011 Elsevier Inc. All rights reserved.